4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-000755
Chief Financial Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2022-12-30 | Option exercise | +5,000 | $6.88 | $34,400 | 36,667 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2022-12-30 | Option exercise · Stock Option (Right to Buy) | −5,000 | 447,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…